Roche accuses competitor of infringing diabetes patent

Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia-Pacific

Roche and Innovent unite in $2bn biospecifics deal

15 June 2020 Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.

Americas

Federal Circuit won’t revisit revived Illumina DNA test patents

6 August 2020 The US Court of Appeals for the Federal Circuit will not revisit its ruling that saved the patent eligibility of two DNA test patents owned by biotechnology company Illumina, after the court rejected an en banc request from a subsidiary of Roche.

Big Pharma

Medtronic’s $738m deal with insulin maker at risk

12 October 2023 Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.

More on this story

Americas

Federal Circuit won’t revisit revived Illumina DNA test patents

Asia-Pacific

Roche and Innovent unite in $2bn biospecifics deal

15 June 2020 Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.

Big Pharma

Medtronic’s $738m deal with insulin maker at risk

More on this story

Americas

Federal Circuit won’t revisit revived Illumina DNA test patents

Asia-Pacific

Roche and Innovent unite in $2bn biospecifics deal

15 June 2020 Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.

Big Pharma

Medtronic’s $738m deal with insulin maker at risk